AGTR1 and Alzheimer disease: There is evidence indicating that RAS blockade by orally administered ACE inhibitors (ACEI) or AT1R blockers (ARBs), e.g perindopril or telmisartan respectively, may have a beneficial effect on cognitive functions in AD [31–36].